Sirolimus-eluting stent treatment at high-volume centers confers lower mortality at 6-month follow-up: Results from the prospective multicenter german cypher registry

Circulation

Volumn 120, Issue 7, 2009, Pages 600-606

  Khattab, Ahmed A ^a,l   Hamm, Christian W ^b   Senges, Jochen ^c   Toelg, Ralph ^a   Geist, Volker ^a   Bonzel, Tassilo ^d   Kelm, Malte ^e   Levenson, Benny ^f   Nienaber, Christoph A ^g   Pfannebecker, Thomas ^h   Sabin, Georg ⁱ   Schneider, Steffen ^c   Tebbe, Ulrich ^j   Neumann, Franz Josef ^k   Richardt, Gert ^a  

^a Segeberger Kliniken GmbH   (Germany)

^b KERCKHOFF HEART CENTER   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d KLINIKUM FULDA   (Germany)

^e UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^f Kardiologische Praxis   (Germany)

^g ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^h Medical Affairs   (Germany)

ⁱ ELISABETH KRANKENHAUS ESSEN   (Germany)

^j KLINIKUM LIPPE DETMOLD   (Germany)

^k UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^l PSI   (Switzerland)

more..

Author keywords

Mortality; Restenosis; Stents

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLOPIDOGREL; CYPHER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; RAPAMYCIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY STENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HOSPITAL DISCHARGE; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVASCULARIZATION; STATISTICAL SIGNIFICANCE; STENT THROMBOSIS; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CLINICAL COMPETENCE; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; QUALITY ASSURANCE, HEALTH CARE; REGISTRIES; RISK FACTORS; SIROLIMUS; TREATMENT OUTCOME;

EID: 69549135341     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.810333     Document Type: Article

References (18)

1. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kern MJ, King SB III, Morrison DA, O'Neill WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (ACC/ AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol. 2006;47:216-235.
2. McGrath PD, Wennberg DE, Dickens JD Jr, Siewers AE, Lucas FL, Malenka DJ, Kellett MA Jr, Ryan TJ Jr. Relation between operator and hospital volume and outcomes following percutaneous coronary interventions in the era of the coronary stent. JAMA. 2000;284:3139-3144.
3. Ryan TJ. The critical question of procedure volume minimums for coronary angioplasty. JAMA. 1995;274:1169-1170.
4. Epstein AJ, Rathore SS, Volpp KG, Krumholz HM. Hospital percutaneous coronary intervention volume and patient mortality, 1998 to 2000: does the evidence support current procedure volume minimums? J Am Coll Cardiol. 2004;43:1755-1762.
5. Brown DL. Analysis of the institutional volume-outcome relations for balloon angioplasty and stenting in the stent era in California. Am Heart J. 2003;146:1071-1076.
6. Every NR, Maynard C, Schulman K, Ritchie JL. The association between institutional primary angioplasty procedure volume and outcome in elderly Americans. J Invasive Cardiol. 2000;12:303-308.
7. Magid DJ, Calonge BN, Rumsfeld JS, Canto JG, Frederick PD, Every NR, Barron HV; National Registry of Myocardial Infarction 2 and 3 Investigators. Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy. JAMA. 2000;284:3131-3138.
8. Zahn R, Hamm CW, Zeymer U, Schneider S, Nienaber CA, Richardt G, Kelm M, Levenson B, Bonzel T, Tebbe U, Schobel WA, Sabin G, Senges J. Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany: results from the prospective multi-centre German Cypher Registry. Herz. 2004;29:181-186. (Pubitemid 38495892)
9. Zahn R, Hamm CW, Zeymer U, Schneider S, Nienaber CA, Richardt G, Kelm M, Levenson B, Bonzel T, Tebbe U, Schobel WA, Sabin G, Senges J. "Real life" use of sirolimus-eluting coronary stents in Germany: results from the prospective multi-centre German Cypher Registry. Z Kardiol. 2003;93:287-294.
10. Zahn R, Hamm CW. Schneider S, Zeymer U, Richardt G, Kelm M, Levenson B, Bonzel T, Tebbe U, Sabin G, Nienaber CA, Pfannebecker T, Senges J. The sirolimus-eluting coronary stent in daily routine practice in Germany: trends in indications over the years. Clin Res Cardiol. 2007;8:548-556.
11. Zahn R, Hamm CW, Schneider S, Zeymer U, Richardt G, Kelm M, Levenson B, Bonzel T, Tebbe U, Sabin G, Nienaber CA, Senges J. Predictors of death or myocardial infarction during follow-up after coronary stenting with the sirolimus-eluting stent. Am Heart J. 2006;6:1146-1152.
12. Jollis JG, Peterson ED, DeLong ER, Mark DB, Collins SR, Muhlbaier LH, Pryor DB. The relation between the volume of coronary angioplasty procedures at hospitals treating Medicare beneficiaries and short-term mortality. N Engl J Med. 1994;331:1625-1629.
13. Serruys P. Presented at: 28th European Congress of Cardiology/World Congress of Cardiology; Barcelona, Spain; September 2006. Discussed in: Clappers N, Verheugt FW. Hotline sessions of the 28th European Congress of Cardiology/World Congress of Cardiology 2006. Eur Heart J. 2006;27:2896-2899.
14. Bavry AA, Kumbhant DJ, Helton TJ, Borek PP, Mood GR, Bhatt DL. Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. Am J Med. 2006;119:1056-1061.
15. Hodgson J, Stone GW, Lincoff AM, Klein L, Walpole H, Bottner R, Weiner BH, Leon MB, Feldman T, Babb J, Dehmer GJ. Late stent thrombosis: considerations and practical advice for the use of drug-eluting stents: a report from the Society for Cardiovascular Angiography and Interventions Drug-Eluting Stent Task Force. Catheter Cardiovasc Interv. 2007;69:327-333.
16. Cheneau E, Satler LF, Escolar E, Suddath WO, Kent KM, Weissman NJ, Waksman R, Pichard AD. Underexpansion of sirolimus-eluting stents: incidence and relationship to delivery pressure. Catheter Cardiovasc Interv. 2005;65:222-226.
17. Wenaweser P, Daemen J, Zwahlen M, van Domburg R, Jüni P, Vaina S, Hellige G, Tsuchida K, Morger C, Boersma E, Kukreja N, Meier B, Serruys PW, Windecker S. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. J Am Coll Cardiol. 2008;52:1134-1140.
18. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344-2351.